198 related articles for article (PubMed ID: 22613717)
1. Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells.
Knezević J; Pavlinić D; Rose WA; Leifer CA; Bendelja K; Gabrilovac J; Parcina M; Lauc G; Kubarenko AV; Petricevic B; Vrbanec D; Bulat-Kardum L; Bekeredjian-Ding I; Pavelić J; Dembić Z; Weber AN
J Biol Chem; 2012 Jul; 287(29):24544-53. PubMed ID: 22613717
[TBL] [Abstract][Full Text] [Related]
2. A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.
Kubarenko AV; Ranjan S; Rautanen A; Mills TC; Wong S; Vannberg F; Neumaier M; Bekeredjian-Ding I; Hill AV; Ahmad-Nejad P; Weber AN
J Biol Chem; 2010 Nov; 285(47):36486-94. PubMed ID: 20843814
[TBL] [Abstract][Full Text] [Related]
3. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
5. Involvement of DNA-PKcs in the IL-6 and IL-12 response to CpG-ODN is mediated by its interaction with TRAF6 in dendritic cells.
Ma C; Muranyi M; Chu CH; Zhang J; Chu WM
PLoS One; 2013; 8(3):e58072. PubMed ID: 23533581
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
Arunkumar N; Liu C; Hang H; Song W
Cell Mol Immunol; 2013 Jul; 10(4):360-72. PubMed ID: 23727784
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
8. CpG oligonucleotides induce an immune response of odontoblasts through the TLR9, MyD88 and NF-kappaB pathways.
He W; Yu Q; Zhou Z; Wang P
Biochem Biophys Res Commun; 2010 Aug; 399(2):274-8. PubMed ID: 20655295
[TBL] [Abstract][Full Text] [Related]
9. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
[TBL] [Abstract][Full Text] [Related]
10. CpG ODN 2102 promotes antibacterial immune responses and enhances vaccine-induced protection in golden pompano (Trachinotusovatus).
Chen X; Wu Y; Qiu Y; Li P; Cao Z; Zhou Y; Sun Y
Fish Shellfish Immunol; 2023 Jun; 137():108783. PubMed ID: 37137380
[TBL] [Abstract][Full Text] [Related]
11. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.
Assaf A; Esteves H; Curnow SJ; Browning MJ
Cell Immunol; 2009; 259(1):90-9. PubMed ID: 19573862
[TBL] [Abstract][Full Text] [Related]
12. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W
Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095
[TBL] [Abstract][Full Text] [Related]
14. CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells.
Blaas SH; Stieber-Gunckel M; Falk W; Obermeier F; Rogler G
Clin Exp Immunol; 2009 Mar; 155(3):534-40. PubMed ID: 19220839
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
16. Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners.
Ma C; Spies NP; Gong T; Jones CX; Chu WM
PLoS One; 2015; 10(3):e0121371. PubMed ID: 25812014
[TBL] [Abstract][Full Text] [Related]
17. High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.
Volpi C; Fallarino F; Pallotta MT; Bianchi R; Vacca C; Belladonna ML; Orabona C; De Luca A; Boon L; Romani L; Grohmann U; Puccetti P
Nat Commun; 2013; 4():1852. PubMed ID: 23673637
[TBL] [Abstract][Full Text] [Related]
18. Expression of Toll-like receptor9 in diffuse large B-cell lymphoma: further exploring CpG oligodeoxynucleotide in NFκB pathway.
Huang WT; Weng SW; Huang CC; Lin HC; Tsai PC; Chuang JH
APMIS; 2012 Nov; 120(11):872-81. PubMed ID: 23009111
[TBL] [Abstract][Full Text] [Related]
19. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.
Ivanov S; Dragoi AM; Wang X; Dallacosta C; Louten J; Musco G; Sitia G; Yap GS; Wan Y; Biron CA; Bianchi ME; Wang H; Chu WM
Blood; 2007 Sep; 110(6):1970-81. PubMed ID: 17548579
[TBL] [Abstract][Full Text] [Related]
20. TLR9 activation is defective in common variable immune deficiency.
Cunningham-Rundles C; Radigan L; Knight AK; Zhang L; Bauer L; Nakazawa A
J Immunol; 2006 Feb; 176(3):1978-87. PubMed ID: 16424230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
